Literature DB >> 9299621

Involvement of human immunodeficiency virus type-1 splice sites in the cytoplasmic accumulation of viral RNA.

K T Borg1, J P Favaro, S J Arrigo.   

Abstract

To define the role of human immunodeficiency virus type 1 splice sites in the cytoplasmic accumulation of viral RNAs, sequential deletion mutagenesis on an infectious proviral clone of HIV-1 was performed. Deletion of the majority of intron sequences, containing previously identified CRS, did not attenuate CRS activity. Retention of either the first or second tat intron preserved CRS activity. RNAs containing splice donor sequences, in the absence of known downstream splice acceptor sequences, retained CRS activity. Unexpectedly, these splice donors were still utilized for splicing. These results indicate that the major HIV-1 splice donors can function as CRS and function to negatively regulate the cytoplasmic accumulation of HIV-1 RNAs in COS cells. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299621     DOI: 10.1006/viro.1997.8726

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

Review 1.  Transcriptional and posttranscriptional regulation of HIV-1 gene expression.

Authors:  Jonathan Karn; C Martin Stoltzfus
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

2.  Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function.

Authors:  Y Cui; T Iwakuma; L J Chang
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  Control of human immunodeficiency virus type 1 RNA metabolism: role of splice sites and intron sequences in unspliced viral RNA subcellular distribution.

Authors:  B Séguin; A Staffa; A Cochrane
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

Review 4.  Sequence Determinants for Nuclear Retention and Cytoplasmic Export of mRNAs and lncRNAs.

Authors:  Alexander F Palazzo; Eliza S Lee
Journal:  Front Genet       Date:  2018-10-17       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.